weight-loss and diet control industry
Page 4 of 10
By BloombergAugust 7, 2024
FinanceSwiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By Prarthana PrakashJuly 29, 2024
By Lindsey LeakeJuly 18, 2024
HealthDanone and Nestle search for a way around Ozempic Revolution with high protein yogurt and vitamins against hair-loss
By Dasha Afanasieva, Deena Shanker and BloombergJune 24, 2024
RetailOzempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By Ryan HoggJune 17, 2024
HealthSugar substitute xylitol may increase your risk of heart attack and stroke, new study shows. What to know about the low-calorie sweetener
By Lindsey LeakeJune 14, 2024
By Emma Hinchliffe and Joey AbramsJune 11, 2024
HealthGLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By Lindsey LeakeMay 22, 2024
RetailNestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By Sasha RogelbergMay 21, 2024
ConferencesHims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
By Marco Quiroz-GutierrezMay 20, 2024
HealthHims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By Madison Muller, Jessica Nix and BloombergMay 20, 2024
HealthWeaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By Ashleigh Furlong and BloombergMay 11, 2024
RetailDenmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
By Maysoon Khan and The Associated PressApril 25, 2024
Most Popular
